Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 12,572 shares at $73.06 ($917K) on 2026-05-14, disclosed to the SEC on 2026-05-15.
Open-market sale of $917k PTCT by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.46 | 2,572 | $186K | 20.3% |
| 2 | $73.06 | 679 | $50K | 5.4% |
| 3 | $73.08 | 2,100 | $153K | 16.7% |
| 4 | $73.08 | 7,221 | $528K | 57.5% |
| Total | $72.95 avg | 12,572 | $917K | 100% |
| Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |
| PTCT | SELL | 2026-02-20 | $511K | — | Filing → |